What’s Wrong With the Fine Print at the FDA
NegativeU.S News

The FDA's stringent requirement for 'substantial evidence' is raising concerns about its impact on drug efficacy evaluations. This overcaution may hinder the approval of potentially beneficial treatments, affecting patients who rely on timely access to effective medications. Understanding these implications is crucial as it highlights the balance between safety and accessibility in healthcare.
— Curated by the World Pulse Now AI Editorial System